• Fri, January 7, 2022
David Amsellem Upgraded (AMPH) to Buy and Increased Target to $28 on, Jan 7th, 2022
David Amsellem of Piper Sandler, Upgraded "Amphastar Pharmaceuticals, Inc." (AMPH) to Buy and Increased Target from $21 to $28 on, Jan 7th, 2022.
David, nor any peers, have made any analyst calls on AMPH in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
